Cite

    Dunlop, A. J., Brown, A. L., Oldmeadow, C., Harris, A., Gill, A., Sadler, C., Ribbons, K., Attia, J., Barker, D., Ghijben, P., Hinman, J., Jackson, M., Bell, J., & Lintzeris, N. (2017). effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial. Drug and alcohol dependence, 174, 181–191. http://access.bl.uk/ark:/81055/vdc_100045516698.0x000019